- Home
- ADM vs BNTX Comparison
ADM vs BNTX Comparison
Compare ADM & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADM
- BNTX
- Stock Information
- Founded
- ADM 1902
- BNTX 2008
- Country
- ADM United States
- BNTX Germany
- Employees
- ADM N/A
- BNTX N/A
- Industry
- ADM Packaged Foods
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ADM Consumer Staples
- BNTX Health Care
- Exchange
- ADM Nasdaq
- BNTX Nasdaq
- Market Cap
- ADM 25.4B
- BNTX 23.9B
- IPO Year
- ADM N/A
- BNTX 2019
- Fundamental
- Price
- ADM $50.63
- BNTX $114.13
- Analyst Decision
- ADM Hold
- BNTX Strong Buy
- Analyst Count
- ADM 12
- BNTX 15
- Target Price
- ADM $60.92
- BNTX $143.50
- AVG Volume (30 Days)
- ADM 3.4M
- BNTX 659.5K
- Earning Date
- ADM 11-18-2024
- BNTX 11-04-2024
- Dividend Yield
- ADM 3.96%
- BNTX N/A
- EPS Growth
- ADM N/A
- BNTX N/A
- EPS
- ADM 3.56
- BNTX N/A
- Revenue
- ADM $87,010,000,000.00
- BNTX $3,390,698,192.00
- Revenue This Year
- ADM N/A
- BNTX N/A
- Revenue Next Year
- ADM $2.13
- BNTX N/A
- P/E Ratio
- ADM $14.24
- BNTX N/A
- Revenue Growth
- ADM N/A
- BNTX N/A
- 52 Week Low
- ADM $48.92
- BNTX $76.53
- 52 Week High
- ADM $74.02
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- ADM 40.06
- BNTX 49.15
- Support Level
- ADM $49.25
- BNTX $109.52
- Resistance Level
- ADM $50.97
- BNTX $115.34
- Average True Range (ATR)
- ADM 1.19
- BNTX 4.74
- MACD
- ADM -0.11
- BNTX -0.80
- Stochastic Oscillator
- ADM 33.66
- BNTX 29.03
About ADM Archer-Daniels-Midland Company
Archer-Daniels Midland is a major processor of oilseeds, corn, wheat, and other agricultural commodities. The company is also one of the largest grain merchandisers through its extensive network of logistical assets to store and transport crops around the globe. ADM also runs a nutrition business that focuses on both human and animal ingredients and is a large producer of corn-based sweeteners, starches, and ethanol.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.